CCL11 and sarcoma: Experimental evidence from Xing et al. demonstrates that recombinant CCL11 induces macrophage differentiation from bone marrow precursors, generating M0-, M1-, and M2-like phenotypes through prolonged exposure (7 days) to conditioned medium from CCL11-overexpressing murine sarcoma cells (MS-Ks) [49].